Vamorolone
Commons · Question 62450 · Tabled 24 Jun 2025 · Department of Health and Social Care · Official record
Answered 30 Jun 2025
Question
Asked by Freddie van Mierlo
To ask the Secretary of State for Health and Social Care, how many patients have accessed Vamorolone since it was given NICE approval for Duchenne Muscular Dystrophy; what assessment he has made of the adequacy of availability of Vamorolone to patients wi
Answer
Answered by Karin Smyth, 30 Jun 2025
The National Institute for Health and Care Excellence (NICE) published its technology appraisal, titled Vamorolone for treating Duchenne muscular dystrophy in people 4 years and over, on 16 January 2025. NHS England routinely commissioned vamorolone in li...